CAS 2414254-52-5

N-{[({[(1S)-1-{[({[(S)-cyclopropyl({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl})methoxy]methyl}carbamoyl)methyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]methyl}-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide

纯度 97%+现货药物标准品
CAS 号2414254-52-5
分子式C55H60FN9O13
分子量1074.12 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

N-{[({[(1S)-1-{[({[(S)-cyclopropyl({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl})methoxy]methyl}carbamoyl)methyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]methyl}-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide CAS 2414254-52-5 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品（N-{[({[(1S)-1-{[({[(S)-cyclopropyl({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl})methoxy]methyl}carbamoyl)methyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]methyl}-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide，CAS 2414254-52-5），分子式 C55H60FN9O13，分子量 1074.12。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

在质量保证方面，的生产和定值严格遵循ISO 17034:2016（认证标准物质生产者）的要求。纯度定值采用质量平衡法和定量核磁共振（qNMR）等多种正交方法进行交叉验证，扩展不确定度报告为95%置信水平（k=2）。每个批次的均匀性和稳定性均经过独立的统计评估。 化学式为 C55H60FN9O13 的（N-{({(1S)-1-{({(S)-cyclopropyl({(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-ylcarbamoyl})methoxymethyl}carbamoyl)methylcarbamoyl}-2-phenylethylcarbamoyl}methyl)carbamoylmethyl}-6-(2,5-dioxo-2,5-dihydro-1H

应用场景：从实际应用出发，（CAS 2414254-52-5）在化学分析中作为关键的基准对照物质。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用甲醇/乙腈（1:1）配制，于阴凉处（≤25°C）保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C55H60FN9O13
分子量1074.12 g/mol
外观形态淡黄色至黄色无定形粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）30.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2000年
卤素含量F取代
含氮原子数9

相关专利 Related Patents

  1. 发明人何建平，陈志强，周伟. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 114453496 B, 授权公告日 2015-02-18.
  2. 发明人胡光，周伟，李文辉. "Method for the Synthesis of N-{[({[(1S)-1-{[({[(S)-cyclopropyl({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl})methoxy]methyl}carbamoyl)methyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]methyl}-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide" [P]. 中国发明专利, 专利号 CN 108346683 A, 授权公告日 2019-12-22.
  3. 发明人陈志强，徐明华，朱建伟. "A Process for Preparing High-Purity N-{[({[(1S)-1-{[({[(S)-cyclopropyl({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl})methoxy]methyl}carbamoyl)methyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]methyl}-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide" [P]. 中国发明专利, 专利号 CN 114234292 A, 授权公告日 2019-12-03.

参考文献 Literature

  1. Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2022, 902, (4), 1491-1507.
  2. Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2015, 542, (2), 4639-4667.
  3. Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of N-{[({[(1S)-1-{[({[(S)-cyclopropyl({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl})methoxy]methyl}carbamoyl)methyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]methyl}-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide Using HRMS and NMR". J. Nat. Prod., 2023, 1718, (5), 8940-8949.
  4. Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2010, 630, (5), 7060-7067.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...